Related Experiment Video
Updated: Aug 5, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Dynamic Co-Evolution of Obesity-Metabolic-Inflammatory for Cardiovascular Disease Risk Stratification in Middle-Aged
Qinggao Wang1, Yilu Lei2, Qingfeng Zhou3
1Department of Cardiology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, China.
Background:
Cardiovascular disease (CVD) risk assessment based on single-time-point measurements may inadequately capture the dynamic interplay of obesity, metabolic dysfunction, and chronic inflammation. Understanding their long-term co-evolution may improve CVD risk stratification.
Methods:
We conducted a prospective cohort study using data from the China Health and Retirement Longitudinal Study. Participants aged ≥ 45 years with repeated measurements of body mass index (BMI), triglyceride-glucose (TyG) index, and high-sensitivity C-reactive protein (hsCRP) between 2011 and 2015 were included. Joint trajectories of these obesity-metabolic-inflammatory markers were identified using the KmL3D clustering algorithm. Incident CVD (heart disease or stroke) was ascertained during follow-up from 2015 to 2020. Cox proportional hazards models were applied to evaluate associations between trajectory groups and CVD risk after adjustment for demographic, lifestyle, and clinical covariates.
Results:
Among 4483 participants (mean age 57.8 years; 52.6% women), four distinct joint trajectory patterns were identified: a sustained low-risk profile (46.8%), an obesity-predominant profile (26.7%), a metabolic-obesity-driven profile (17.1%), and an inflammation-dominant profile (9.4%). During a median follow-up of 5.0 years, 592 incident CVD events occurred. Compared with the low-risk profile, all adverse trajectory groups were associated with significantly higher CVD risk, with hazard ratios ranging from 1.35 to 1.46 after full adjustment. Associations were more pronounced for stroke, particularly among individuals with a metabolic-obesity-driven trajectory. Findings were robust across sensitivity analyses.
Conclusions:
Distinct dynamic co-evolution patterns of obesity, metabolic dysfunction, and inflammation identify population subgroups with substantially different risks of incident CVD.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Type II Diabetes II: Pathophysiology
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
